Lead party: AfricInvest Capital Partners LLC (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: 54Gene, Inc. (private company) · Sector: Healthcare, Biotechnology · Countries of operation: Nigeria
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Equity · Round: Series B · Deal amount: US$25m · Fund: KdT Ventures Fund II, LP
Lead investor/buyer: AfricInvest Capital Partners LLC · Investors/buyers: AfricInvest Capital Partners LLC, Adjuvant Capital, KdT Ventures LLC, Plexo Capital Management, LLC, Endeavor Catalyst, Ingressive Capital
Legal advisers: not identified in the source record.
Source: announced 16 September 2021. Original announcement: techcrunch.com.


